Business · 26/04/2000Updated: 10/17/2026 · 1 min read
FDA Extends Compliance Date for Levothyroxine Sodium Products
Summary
The FDA is extending the compliance date for manufacturers of orally administered levothyroxine sodium products from August 14, 1997, to August 14, 2001, to allow additional time for studies and application preparation.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →